Bio Essence Corp
OTC · CIK 0001723059 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$500,537
Cost Of Revenue
$181,184
Gross Profit
$319,353
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $500,537 | - | - |
| Cost Of Revenue | $181,184 | - | - |
| Gross Profit | $319,353 | - | - |
| Operating Income | $215,795 | - | - |
| Net Income | $205,373 | - | - |
| Total Assets | $789,032 | - | - |
| Total Liabilities | $2.2M | - | - |
| Shareholders Equity | $-1.4M | - | - |
| Operating Cash Flow | $-411,970 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Bio Essence Corp | 2026-05-15 | 0001213900-26-057529 |
| 10-K | Bio Essence Corp | 2026-03-27 | 0001213900-26-035467 |
| 10-Q | Bio Essence Corp | 2025-11-12 | 0001213900-25-108357 |
| 10-Q | Bio Essence Corp | 2025-08-14 | 0001213900-25-076353 |